NCT02760979View on ClinicalTrials.gov

The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

June 30, 2015

Conditions
Bone Resorption
Interventions
DRUG

Denosumab

Denosumab treatment one year after surgery

DRUG

Placebo

Serum one year after surgery

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT02760979 - The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter